Prism Medico & Pharmacy Ltd. Press Release Aug 12 2026

Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we are pleased to inform you that the Board of Directors at their meeting held today (i.e. 12th August, 2026) which commenced at 01:30 P.M. and concluded at 03:30 P.M. have inter alia approved the following:? The Board considered and approved the Unaudited Standalone Financial Results of the company for the quarter ended 30th June, 2026 alongwith the Limited Review Report duly signed by the Auditors of the company. You are requested to kindly take the same on record and oblige.

View Attachment